SVB Leerink Initiates Coverage On Graphite Bio with Outperform Rating, Announces Price Target of $34
SVB Leerink analyst Mani Foroohar initiates coverage on Graphite Bio (NASDAQ:GRPH) with a Outperform rating and announces Price Target of $34.